Company / Current Assets
Abbott Laboratories Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$26.0B
FY2025
5-year range
$22.7B / $26.0B
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#11 of 160
Health Care
What the data says
Among 160 Health Care companies, Abbott Laboratories is in the top 7% for current assets. Current Assets has fluctuated over the past 10 years, ranging from $14.6B in FY2018 to $26.8B in FY2016.
Based on SEC 10-K filings.
$26.0B in FY2025 with a 5-year CAGR of +4.9%. Top quartile in the Health Care sector.
Improved from $22.7B to $26.0B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +4.9%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 160This company $26.0B Sector average $5.2B
▼
+396.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +4.9%, indicating consistent growth.
- In FY2025, current assets increased 9.9% year-over-year.
- Ranks #11 out of 160 companies in the Health Care sector.
- Peak current assets was recorded in FY2016.
Company context
Key Data Points
- Strong profit margin: 31.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 27.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.0B | +9.9% |
| FY2024 | $23.7B | +4.3% |
| FY2023 | $22.7B | -10.1% |
| FY2022 | $25.2B | +4.1% |
| FY2021 | $24.2B | +18.6% |
| FY2020 | $20.4B | +30.5% |
| FY2019 | $15.7B | +7.1% |
| FY2018 | $14.6B | -27.4% |
| FY2017 | $20.1B | -24.8% |
| FY2016 | $26.8B | +89.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026